Ligand-targeted delivery of small interfering RNAs to malignant cells and tissues

Annals of the New York Academy of Sciences

Volumn 1175, Issue , 2009, Pages 32-39

  Thomas, Mini ^a   Kularatne, Sumith A ^a   Qi, Longwu ^b   Kleindl, Paul ^b   Leamon, Christopher P ^b   Hansen, Michael J ^a   Low, Philip S ^a  

^a PURDUE UNIVERSITY   (United States)

^b Endocyte Inc   (United States)

Author keywords

DUPA; Endosomal escape; Folate receptor; PSMA; SiRNA; SiRNA targeting

Indexed keywords

FOLATE RECEPTOR; FOLIC ACID; FOLIC ACID SMALL INTERFERING RNA CONJUGATE; LIGAND; OLIGONUCLEOTIDE; PROSTATE SPECIFIC MEMBRANE ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; [2 [3 (1,3 DICARBOXY PROPYL) UREIDO] PENTANEDIOIC ACID] SMALL INTERFERING RNA CONJUGATE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; CANCER CELL; CHO CELL; CONFERENCE PAPER; DRUG RECEPTOR BINDING; FEMALE; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIGAND BINDING; MALE; MOUSE; NONHUMAN; PROSTATE CANCER; PROTEIN EXPRESSION; SOLID TUMOR;

EID: 70349451255     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04977.x     Document Type: Conference Paper

References (20)

1. Walchli S. M. Sioud. 2008. Vector-based delivery of siRNAs: in vitro and in vivo challenges. Front. Biosci. 13 : 3488 3493.
2. Llano M., N. Gaznick, & E.M. Poeschla. 2009. Rapid, controlled and intensive lentiviral vector-based RNAi. Methods Mol. Biol. 485 : 257 270.
3. Kaiser, J. 2004. Side effects sideline hemophilia trial. Science 304 : 1423 1425.
4. Marshall, E. 1999. Gene therapy death prompts review of adenovirus vector. Science 286 : 2244 2245.
5. Check, E. 2005. Gene therapy put on hold as third child develops cancer. Nature 433 : 561.
6. Marshall, E. 2001. Panel reviews risks of germ line changes. Science 294 : 2268 2269.
7. Porada, C.D., P.J. Park, J. Tellez, et al. 2005. Male germ-line cells are at risk following direct-injection retroviral-mediated gene transfer in utero. Mol. Ther. 12 : 754 762.
8. Meidan, V.M. B.B. Michniak. 2004. Emerging technologies in transdermal therapeutics. Am. J. Ther. 11 : 312 316.
9. Medina-Kauwe, L.K., J. Xie, & S. Hamm-Alvarez. 2005. Intracellular trafficking of non-viral vectors. Gene Ther. 12 : 1734 1751.
10. Thomas, M., J.J. Lu, Q. Ge, et al. 2005. Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. Proc. Natl. Acad. Sci. USA 102 : 5679 5684.
11. Thomas, M., Q. Ge, J.J. Lu, et al. 2005. Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection. Expert Opin. Biol. Ther. 5 : 495 505.
12. Zimmermann, T.S., A.C. Lee, A. Akinc, et al. 2006. RNAi-mediated gene silencing in non-human primates. Nature 441 : 111 114.
13. Low, P.S., W.A. Henne, & D.D. Doorneweerd. 2008. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc. Chem. Res. 41 : 120 129.
14. Parker, N., M.J. Turk, E. Westrick, et al. 2005. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal. Biochem. 338 : 284 293.
15. Israeli, R.S., C.T. Powell, J.G. Corr, et al. 1994. Expression of the prostate-specific membrane antigen. Cancer Res. 54 : 1807 1811.
16. Sokoloff, R.L., K.C. Norton, C.L. Gasior, et al. 2000. A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine. Prostate 43 : 150 157.
17. Liu, H., A.K. Rajasekaran, P. Moy, et al. 1998. Constitutive and antibody-induced internalization of prostate-specific membrane antigen. Cancer Res. 58 : 4055 4060.
18. Kularatne, S.A. et al. 2009. Prostate-specific membrane antigen (PSMA)-targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand. Mol. Pharm. 6 : 780 789.
19. Kularatne, S.A. et al. 2009. Design, synthesis, and pre-clinical evaluation of prostate-specific membrane antigen (PSMA)-targeted 99mTc-radioimaging agents. Mol. Pharm. 6 : 790 800.
20. Chen, H., J. Yang, P.S. Low, et al. 2008. Cholesterol level regulates endosome motility via Rab proteins. Biophys. J. 94 : 1508 1520.